Citius Oncology CTOR
NASDAQ CTOR
$0.57 +0.01 (+2.23%)
As of: Nov 12, 2026 · 11:05 AM EST

Citius Oncology (CTOR) Interest & Investment Income (2023 - 2026)

Updated

Citius Oncology's Interest & Investment Income came in at $96,848 for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 121.5% from the prior quarter.

Analysis

Citius Oncology (CTOR) Interest & Investment Income (2023 - 2026) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Citius Oncology's Interest & Investment Income was $36,373.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 186.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 67.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Citius Oncology 60.42 Mn 30.00 Mn 1.00 Mn 96,848.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 96,848.00
Mar 31, 2026 43,721.00
Dec 31, 2025 28,288.00
Jun 30, 2024 636,419.00
Mar 31, 2024 758,258.00
Sep 30, 2023 579,398.00
Jun 30, 2023 815,850.00
Mar 31, 2023 759,647.00
API Access

Citius Oncology Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=CTOR&period=max&api_key=YOUR_API_KEY